| 000 | 01312 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513121728.0 | ||
| 264 | 0 | _c19970905 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0033-3158 | ||
| 024 | 7 |
_a10.1007/s002130050282 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGriebel, G | |
| 245 | 0 | 0 |
_aBehavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cMay 1997 |
||
| 300 |
_a180-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnxiety _xdrug therapy |
| 650 | 0 | 4 |
_aAvoidance Learning _xdrug effects |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMoclobemide |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aOxazoles _xpharmacology |
| 650 | 0 | 4 |
_aPanic Disorder _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aPerrault, G | |
| 700 | 1 | _aSanger, D J | |
| 773 | 0 |
_tPsychopharmacology _gvol. 131 _gno. 2 _gp. 180-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002130050282 _zAvailable from publisher's website |
| 999 |
_c9182319 _d9182319 |
||